Abstract
The concurrent prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East respiratory syndrome coronavirus (MERS-CoV) raises the concern for the emergence of potential new β-CoV clades via genetic recombination, bearing high SARS-CoV-2-like transmissibility and high MERS-CoV-like mortality rates. Therefore, we argue that there is an urgent need to develop pan-β-CoV vaccines that can target not only current SARS-CoV-2 variants of concern, but also future putative SARS-CoV-3- or MERS-CoV-2-like coronavirus.
All Keywords
【초록키워드】 SARS-CoV-2, Vaccine, coronavirus, Genetic, SARS-CoV-2 variant, MERS, severe acute respiratory syndrome Coronavirus, MERS-CoV, Prevalence, Transmissibility, Recombination, Middle East respiratory syndrome Coronavirus, clade, mortality rates, Middle East, genetic recombination, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, respiratory syndrome coronavirus, β-CoV, raise, develop, SARS-CoV-3, 【제목키워드】 Vaccine, SARS-CoV-2 variant, Developing,
【초록키워드】 SARS-CoV-2, Vaccine, coronavirus, Genetic, SARS-CoV-2 variant, MERS, severe acute respiratory syndrome Coronavirus, MERS-CoV, Prevalence, Transmissibility, Recombination, Middle East respiratory syndrome Coronavirus, clade, mortality rates, Middle East, genetic recombination, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, respiratory syndrome coronavirus, β-CoV, raise, develop, SARS-CoV-3, 【제목키워드】 Vaccine, SARS-CoV-2 variant, Developing,
{{{ 추상적인 }}}
중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2)와 중동호흡기증후군 코로나바이러스(MERS-CoV)의 동시 유병률은 높은 SARS-CoV를 보유하는 유전적 재조합을 통한 잠재적인 새로운 β-CoV 분기군의 출현에 대한 우려를 높입니다. -2 유사 전염성 및 높은 MERS-CoV 유사 사망률. 따라서 우리는 현재 우려되는 SARS-CoV-2 변이체뿐만 아니라 미래에 추정되는 SARS-CoV-3- 또는 MERS-CoV-2-를 표적으로 할 수 있는 pan-β-CoV 백신 개발이 시급하다고 주장합니다. 코로나바이러스처럼.